InvestorsHub Logo
Followers 9
Posts 1217
Boards Moderated 0
Alias Born 03/13/2013

Re: Rawnoc post# 5029

Thursday, 04/25/2013 8:38:51 AM

Thursday, April 25, 2013 8:38:51 AM

Post# of 430301
A factual term of reference for this opinion would be most helpful. Perhaps a comparison with the Lovaza launch. Personally I am not from the play station generation and do not require such instant gratification. I trust Amarin's management who are seasoned pros and have done this before-most of them with the launch of Lovaza.

They have probably forgotten more than we all know on the do's and dont's of a drug launch!

By October/November we should have a very clear trend and path forward for this company.

In the meantime if I were a short I would beware the black swan event...BO/data from statin combo product/NCE/co-promotion/up tick of RXs..etc,etc.

I can't really see the risk/reward for a short at these levels and with these trading risks but each to their own I guess.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News